In this episode of Oxford+, host Susannah de Jager is joined by Rowan Gardner, co-founder of Precision Life. The topic of discussion delves into the importance of diversifying the investment ecosystem and encouraging more participation from female investors. They also discuss the future of healthcare and the pivotal role AI plays in it, including how AI is reshaping our approach to healthcare, particularly concerning chronic diseases and how we diagnose and treat them.

(0:12) Introduction
(1:10) From Oxford Molecular to Precision Life
(4:03) The Oxford and Cambridge investing landscapes
(15:56) The importance of heterogenous funding sources
(19:49) Fostering diversity and inclusion in investment
(28:18) The Mansion House Accord

About the guest:
Rowan Gardner is a seasoned entrepreneur and CEO with over 30 years of experience in health tech, digital health, deep tech, and biotech. She played a part in one of Oxford University's first spin-outs, Oxford Molecular Group, in 1989 and later listed it on the main London Stock Exchange in 1994. Rowan is a fervent advocate for Oxford and currently serves as the Chief Business and Investment Officer at Precision Life. This platform connects chronic disease patients with the drugs they'll respond to, using mechanistic patient stratification biomarkers.

About the host:
Susannah de Jager is a seasoned professional with over 15 years of experience in UK asset management. She has worked closely with industry experts, entrepreneurs, and government officials to shape the conversation around domestic scale-up capital.

Connect with Susannah on LinkedIn

Visit our website to learn more and subscribe to our newsletter - oxfordplus.co.uk
If you have a question for Susannah, please get in touch - oxfordplus.co.uk/contact

Oxford+ is hosted by Susannah de Jager, supported by Mishcon de Reya and produced and edited by Story Ninety-Four in Oxford.